What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
Guardado en:
Autores principales: | Ivar Sonbo Kristiansen, Stein Kaasa, Christoffer Bugge, Erik Magnus Sæther, Hans Olav Melberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9a4cecc7ab54a898d9af6e9d5a4fb08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Equitable access to cancer patient pathways in Norway – a national registry-based study
por: Frank Olsen, et al.
Publicado: (2021) -
Norwegian physicians' knowledge of and opinions about evidence-based medicine: cross-sectional study.
por: Lidziya Vanahel Ulvenes, et al.
Publicado: (2009) -
Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy
por: Seung Rim Hwang, et al.
Publicado: (2021) -
Impacts of wild fishes attracted to open-cage salmonid farms in Norway
por: I Uglem, et al.
Publicado: (2014) -
I Know What you Did Last Summer
por: Bill Schindler
Publicado: (2013)